XtalPi and Pierre Fabre agree to AI-driven oncology drug discovery collaboration
AIXtalPi and Pierre Fabre announced on November 6, 2026 a collaboration agreement to jointly run several oncology R&D projects and discover new clinical drug candidates. XtalPi will use its integrated "AI+robotics" platform to design and deliver novel small-molecule therapies de novo against undisclosed targets, while Pierre Fabre will select and advance the most promising compounds through clinical and commercial development.
Source details
Leiphone · leiphone.comPublished · added here
Original title: 皮尔法伯集团与晶泰科技达成AI驱动药物发现合作，将在肿瘤领域联合开展多个研发项目